HomeTagsChina

China

Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne

GEN6050X Exon 50 Skipping Base Editing Drug: One-Year Results Show Encouraging Progress for Duchenne Muscular Dystrophy

China-Based Ractigen Therapeutics is Initiating Clinical Trials to Investigate The Safety and Tolerability of RAG-18 in Patients with DMD

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy

SPOT-mRNA03 Gene Therapy for Duchenne Muscular Dystrophy Begins Early Phase 1 Clinical Trial

Belief BioMed Announced Successful Completion of First Dose of BBM-D101 Gene Therapy

BBM-D101 Gene Therapy Phase 1/2 Clinical Trial Begins

Belief BioMed BBM-D101 Gene Therapy Receives IND Clearance by National Medical Products Administration (NMPA)

Shanghai Jiao Tong University School of Medicine Begins Clinical Trials of LE051 Exon 51 Skipping Therapy

12 Page 1 of 2

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

GEN6050X Exon 50 Skipping Base Editing Drug: One-Year Results Show Encouraging Progress for Duchenne Muscular Dystrophy

Sarcomatrix Plans First Human Trial of S-969 for Duchenne Muscular Dystrophy in 2027

7 Breakthrough DMD Research Programs That Could Transform Duchenne Treatment in 2026

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

Deramiocel Shows Positive 24-Month HOPE-3 Results in Duchenne

Press Releases October 5, 2026 0

Capricor Therapeutics has reported new results from the HOPE-3...

Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne

Press Releases October 4, 2026 0

Ractigen Therapeutics has presented positive first-in-human data for RAG-18...

Entrada Therapeutics’ ENTR-601-44 Shows Dose-Dependent Exon 44 Skipping in Early PK/PD Data

Press Releases October 3, 2026 0

Entrada Therapeutics’ ENTR-601-44 is an investigational therapy designed for...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.